Cargando…

Mismatched intratumoral distribution of [18F] fluorodeoxyglucose and 3′-deoxy-3′-[18F] fluorothymidine in patients with lung cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Wang, Xiangcheng, He, Yulin, Zhou, Weina, Bai, Xia, Wu, Yiwei, Wang, Xuemei, Li, Xiao-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063043/ https://www.ncbi.nlm.nih.gov/pubmed/30061957 http://dx.doi.org/10.3892/ol.2018.8756

Ejemplares similares

Mismatched intratumoral distribution of [(18)F] fluorodeoxyglucose and 3′-deoxy-3′-[(18)F] fluorothymidine in patients with lung cancer
por: Wang, Xiangcheng, et al.
Publicado: (2017)

The Influence of Interpreters’ Professional Background and Experience on the Interpretation of Multimodality Imaging of Pulmonary Lesions Using( 18)F-3′-Deoxy-Fluorothymidine and (18)F-Fluorodeoxyglucose PET/CT
por: Xu, Bai-xuan, et al.
Publicado: (2013)

Preclinical Applications of 3'-Deoxy-3'-[(18)F]Fluorothymidine in Oncology - A Systematic Review
por: Schelhaas, Sonja, et al.
Publicado: (2017)

Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
por: Wang, Fu-Li, et al.
Publicado: (2016)

Synthesis and evaluation of 3′-[(18)F]fluorothymidine-5′-squaryl as a bioisostere of 3′-[(18)F]fluorothymidine-5′-monophosphate
por: Brickute, D., et al.
Publicado: (2021)

Relative skeletal distribution of proliferating marrow in the adult dog determined using 3′‐deoxy‐3′‐[(18)F]fluorothymidine
por: Rowe, Joshua A., et al.
Publicado: (2018)

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT in Lung Cancer
por: Kairemo, Kalevi, et al.
Publicado: (2020)

Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study
por: Kairemo, Kalevi, et al.
Publicado: (2020)

[(18)F]fluorothymidine and [(18)F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma
por: Anton-Rodriguez, Jose M., et al.
Publicado: (2019)

The Positron Emission Tomography Tracer 3’-Deoxy-3’-[(18)F]Fluorothymidine ([(18)F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice
por: Wiehr, Stefan, et al.
Publicado: (2016)

Validity of Simplified 3′-Deoxy-3′-[(18)F]Fluorothymidine Uptake Measures for Monitoring Response to Chemotherapy in Locally Advanced Breast Cancer
por: Lubberink, Mark, et al.
Publicado: (2012)

(18)F-fluorothymidine PET imaging in gliomas: an update
por: Nikaki, Alexandra, et al.
Publicado: (2017)

Phosphorylation Status of Thymidine Kinase 1 Following Antiproliferative Drug Treatment Mediates 3′-Deoxy-3′-[(18)F]-Fluorothymidine Cellular Retention
por: Sala, Roberta, et al.
Publicado: (2014)

Clinical value of 3'-deoxy-3'-[(18)F]fluorothymidine-positron emission tomography for diagnosis, staging and assessing therapy response in lung cancer
por: Alwadani, Bandar, et al.
Publicado: (2021)

Comparison of 4′-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3′-deoxy-3′-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging
por: Toyota, Yasunori, et al.
Publicado: (2015)

Exploratory Analysis of (18)F-3’-deoxy-3’-fluorothymidine ((18)F-FLT) PET/CT-Based Radiomics for the Early Evaluation of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
por: Fantini, Lorenzo, et al.
Publicado: (2021)

Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022)

Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses
por: Turcotte, Eric, et al.
Publicado: (2007)

An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography (18)F-FLT PET/CT in Prostate Adenocarcinoma
por: Kairemo, Kalevi, et al.
Publicado: (2017)

3′-Deoxy-3′-[(18)F]-Fluorothymidine PET Imaging Reflects PI3K-mTOR-Mediated Pro-Survival Response to Targeted Therapy in Colorectal Cancer
por: McKinley, Eliot T., et al.
Publicado: (2014)

Voxel-Based Analysis of the Relation of 3′-Deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT) PET and Diffusion-Weighted (DW) MR Signals in Subcutaneous Tumor Xenografts Does Not Reveal a Direct Spatial Relation of These Two Parameters
por: Schelhaas, Sonja, et al.
Publicado: (2021)

18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair
por: Wondergem, Marielle J, et al.
Publicado: (2014)

(18)F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer
por: Wieder, Hinrich, et al.
Publicado: (2018)

(18)F-Fluorodeoxyglucose Uptake and Tumor Hypoxia: Revisit (18)F-Fluorodeoxyglucose in Oncology Application
por: Li, Xiao-Feng, et al.
Publicado: (2014)

Pemetrexed Induced Thymidylate Synthase Inhibition in Non-Small Cell Lung Cancer Patients: A Pilot Study with 3′-Deoxy-3′-[(18)F]fluorothymidine Positron Emission Tomography
por: Frings, Virginie, et al.
Publicado: (2013)

Predictive value of 3′-deoxy-3′-(18)F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer
por: Sato, Masayuki, et al.
Publicado: (2021)

Role of 3'-Deoxy-3'-[(18)F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase
por: Szyszko, Teresa A., et al.
Publicado: (2022)

(18)F-fluorodeoxyglucose (FDG) PET or (18)F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
por: Romine, Perrin E., et al.
Publicado: (2021)

Preliminary (19)F-MRS Study of Tumor Cell Proliferation with 3′-deoxy-3′-fluorothymidine and Its Metabolite (FLT-MP)
por: Ko, In Ok, et al.
Publicado: (2017)

Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using (18)F-Fluorothymidine PET
por: Sharma, Rohini, et al.
Publicado: (2020)

3’-Deoxy-3’-(18F) Fluorothymidine Positron Emission Tomography/Computed Tomography in Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy: A Pilot Study
por: Lewis, Shirley, et al.
Publicado: (2022)

The hot embolus of (18)F-fluorodeoxyglucose
por: Hussain, Riffat Parveen, et al.
Publicado: (2020)

Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
por: Nikaki, Alexandra, et al.
Publicado: (2019)

In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET
por: Wong, Peter K., et al.
Publicado: (2014)

[(18)F]Fluorothymidine Uptake in the Porcine Pancreatic Elastase-Induced Model of Abdominal Aortic Aneurysm
por: Gandhi, Richa, et al.
Publicado: (2021)

Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients with Lung Cancer Treated First-Line with Erlotinib
por: Scheffler, Matthias, et al.
Publicado: (2013)

(18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy
por: Hodolic, Marina, et al.
Publicado: (2016)

[(18)F]Fluorothymidine PET imaging in the diagnosis of leptomeningeal involvement with diffuse large B-cell lymphoma
por: Holter, Jennifer L., et al.
Publicado: (2011)

Corrigendum to “Design of CGMP Production of (18)F- and (68)Ga-Radiopharmaceuticals”
por: Chi, Yen-Ting, et al.
Publicado: (2016)

Evaluation of (18)F-fluorothymidine positron emission tomography ([(18)F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer
por: Sharma, R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8ktl5g45insppab22o0fhivt12